Communications
29 September 2021
Vol. 2 No. 1 (2021)
https://doi.org/10.4081/bse.169

Promising 3D in vitro models for studying tumour heterogeneity and testing novel therapeutic approaches in pancreatic cancer

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
3D tumour models, cancer stem cells, tumour microenvironment, pancreatic ductal adenocarcinoma
696
Views
259
Downloads

Authors

Stefania Forciniti
stefania.forciniti@nanotec.cnr.it
Institute of Nanotechnology, National Research Council (CNR-NANOTEC), Lecce; Department of Neurosciences, Biomedicine and Movement Sciences, Biochemistry Section, University of Verona, Italy.
Marta Cavo
Institute of Nanotechnology, National Research Council (CNR-NANOTEC), Lecce, Italy.
Ilaria Dando
Department of Neurosciences, Biomedicine and Movement Sciences, Biochemistry Section, University of Verona, Italy.
Elisa Dalla Pozza
Department of Neurosciences, Biomedicine and Movement Sciences, Biochemistry Section, University of Verona, Italy.
Marta Palmieri
Department of Neurosciences, Biomedicine and Movement Sciences, Biochemistry Section, University of Verona, Italy.
Loretta L. del Mercato
Institute of Nanotechnology, National Research Council (CNR-NANOTEC), Lecce, Italy.

In this study we produced 3D organotypic cultures and spheroids to mimic the complex microenvironment of pancreatic cancer and to test alternative therapeutic strategies.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite



Promising 3D in vitro models for studying tumour heterogeneity and testing novel therapeutic approaches in pancreatic cancer. (2021). Biomedical Science and Engineering, 2(1). https://doi.org/10.4081/bse.169

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.